SCHEMBL19924569

SCHEMBL19924569

CCN1CCCC1N(C)C(=O)Cl

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
SIGMAR1 Q99720 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DRD2 P14416 5/20 0.32
HSD11B1 P28845 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
BCHE P06276 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16495171 0.84 ALDH1A1 (0.40) ALDH1A1SIGMAR1L3MBTL1HTTRAB9A
SCHEMBL4202588 0.75 L3MBTL1 (0.35) ALDH1A1SIGMAR1L3MBTL1HTTRAB9A
SCHEMBL4202678 0.75 L3MBTL1 (0.35) ALDH1A1SIGMAR1L3MBTL1HTTRAB9A
SCHEMBL21400923 0.75 SIGMAR1 (0.36) ALDH1A1SIGMAR1L3MBTL1HTT
SCHEMBL15652741 0.72 ALDH1A1 (0.33) ALDH1A1SIGMAR1L3MBTL1
SCHEMBL290078 0.71 ALDH1A1 (0.34) ALDH1A1SIGMAR1L3MBTL1HTT
SCHEMBL290079 0.71 ADH1A (0.39) ALDH1A1SIGMAR1L3MBTL1HTT
SCHEMBL9874179 0.70 SIGMAR1 (0.34) ALDH1A1SIGMAR1
SCHEMBL14155721 0.68 BCHE (0.41) ALDH1A1SIGMAR1L3MBTL1HTTRAB9A
SCHEMBL12521647 0.68 BCHE (0.41) ALDH1A1SIGMAR1L3MBTL1HTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504210-A1 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION H. Hoffnabb-La Roche Ag (CH) 2019-07-03 EP disclosed
WO-2018041763-A1 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2018-03-08 WO disclosed